Minjiang Chen
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Lung Cancer Treatments and Mutations 20
- Lung Cancer Diagnosis and Treatment 10
- Ferroptosis and cancer prognosis 9
- Oncology 44
- Cancer Immunotherapy and Biomarkers 26
- Lung Cancer Research Studies 10
- Co-authors
- Jiansong Ji (65 shared papers)Mengzhao Wang (68 shared papers)Qiaoyou Weng (33 shared papers)Yan Xu (69 shared papers)Jing Zhao (58 shared papers)Zhongwei Zhao (37 shared papers)Jiansong Ji (22 shared papers)Shiji Fang (33 shared papers)
- Journals
- Oncotarget (7 papers)Frontiers in Oncology (7 papers)Academic Radiology (6 papers)Frontiers in Immunology (5 papers)BMC Cancer (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Minjiang Chen
193 papers receiving 4.5k citations
Minjiang Chen's Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 722
- Hepatology 334
- Oncology 979
- Pulmonary and Respiratory Medicine 987
- Immunology 478
Countries citing papers authored by Minjiang Chen
This map shows the geographic impact of Minjiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjiang Chen more than expected).
Fields of papers citing papers by Minjiang Chen
This network shows the impact of papers produced by Minjiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjiang Chen. The network helps show where Minjiang Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minjiang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 214 | |
| 2 | 2019 | 214 | |
| 3 | Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response Hit paper breakdown → | 2022 | 182 |
| 4 | Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: roles, opportunities and challenges Hit paper breakdown → | 2023 | 153 |
| 5 | 2012 | 108 | |
| 6 | 2021 | 103 | |
| 7 | 2019 | 88 | |
| 8 | 2021 | 76 | |
| 9 | 2018 | 75 | |
| 10 | 2017 | 73 | |
| 11 | 2021 | 71 | |
| 12 | 2015 | 71 | |
| 13 | 2016 | 66 | |
| 14 | 2019 | 65 | |
| 15 | 2016 | 64 | |
| 16 | 2017 | 63 | |
| 17 | 2020 | 61 | |
| 18 | 2023 | 61 | |
| 19 | 2017 | 58 | |
| 20 | 2019 | 58 |
About Minjiang Chen
Minjiang Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Hepatology and Immunology, having authored 206 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Treatments and Mutations (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Lung Cancer Research Studies (10 papers), Lung Cancer Diagnosis and Treatment (10 papers), Ferroptosis and cancer prognosis (9 papers), Immune cells in cancer (9 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). The work is most often cited by research in Cancer Research (722 citations), Hepatology (334 citations), Oncology (979 citations), Pulmonary and Respiratory Medicine (987 citations) and Immunology (478 citations). Minjiang Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiansong Ji, Mengzhao Wang, Qiaoyou Weng, Yan Xu, Jing Zhao, Zhongwei Zhao, Jiansong Ji, Shiji Fang, Wei Zhong and Jianfei Tu. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Academic Radiology, Frontiers in Immunology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.